EW
USDEdwards Lifesciences Corporation Common Stock
Prix en Temps Réel
Graphique des Prix
Métriques Clés
Métriques de Marché
Ouverture
$83.050
Haut
$84.830
Bas
$82.890
Volume
2.64M
Fondamentaux de l'Entreprise
Capitalisation Boursière
49.4B
Industrie
Dispositifs médicaux
Pays
United States
Statistiques de Trading
Volume Moyen
4.58M
Bourse
NYQ
Devise
USD
Intervalle sur 52 Semaines
Actualités Connexes
Truist Securities Maintains Hold on Edwards Lifesciences, Raises Price Target to $90
Truist Securities analyst Richard Newitter maintains Edwards Lifesciences with a Hold and raises the price target from $87 to $90.
Barclays Maintains Overweight on Edwards Lifesciences, Raises Price Target to $99
Barclays analyst Matt Miksic maintains Edwards Lifesciences with a Overweight and raises the price target from $95 to $99.
Citigroup Maintains Buy on Edwards Lifesciences, Raises Price Target to $96
Citigroup analyst Joanne Wuensch maintains Edwards Lifesciences with a Buy and raises the price target from $95 to $96.
JP Morgan Maintains Neutral on Edwards Lifesciences, Raises Price Target to $90
JP Morgan analyst Robbie Marcus maintains Edwards Lifesciences with a Neutral and raises the price target from $85 to $90.
Goldman Sachs Maintains Buy on Edwards Lifesciences, Raises Price Target to $104
Goldman Sachs analyst David Roman maintains Edwards Lifesciences with a Buy and raises the price target from $94 to $104.
Piper Sandler Reiterates Overweight on Edwards Lifesciences, Raises Price Target to $95
Piper Sandler analyst Adam Maeder reiterates Edwards Lifesciences with a Overweight and raises the price target from $90 to $95.
RBC Capital Maintains Outperform on Edwards Lifesciences, Raises Price Target to $95
RBC Capital analyst Shagun Singh maintains Edwards Lifesciences with a Outperform and raises the price target from $89 to $95.
Actions Connexes
HNRA
HNR Acquisition Corp
RYDE
Ryde Group Ltd. Ordinary Shares
AXSM
Axsome Therapeutics Inc.
HCA
HCA Healthcare Inc.
ETX
Eaton Vance Municipal Income 2028 Term Trust Common Shares of Beneficial Interest
Restez Informé
Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.